Emerging trends and focus of Toll-like receptors in kidney diseases: a 20-year bibliometric analysis
- PMID: 40584714
- PMCID: PMC12202445
- DOI: 10.3389/fmed.2025.1599196
Emerging trends and focus of Toll-like receptors in kidney diseases: a 20-year bibliometric analysis
Abstract
Background: An increasing number of studies have explored the role of Toll-like receptors (TLRs) in the pathogenesis of kidney diseases and their corresponding therapeutic potential. However, there is no comprehensive bibliometric analysis in this field. This study aims to investigate the hotspots and evolution of TLRs and kidney disease research over the past two decades.
Methods: Publications from the Web of Science Core Collection database were searched and extracted on December 21, 2024 using the terms "Toll-like receptor" and "kidney disease" (and their synonyms in MeSH). CiteSpace was used to explore publications from January 1, 2000, to December 21, 2024, to visualize the contributions of countries, institutions, journals, and authors, and to detect the evolution of research focus and emerging trends in this field.
Results: A total of 2,505 studies with 101,150 references were included in this study. The United States and China are the leading forces among all countries. The Egyptian Knowledge Bank is the leading institution, and Hans-Joachim Anders is considered the most influential expert in this field. PLOS One is the journal with the most publications, and Journal of Immunology is the most co-cited journal. According to the co-citation analysis, COVID-19 is the latest research hotspot. Additionally, both ischemia-reperfusion injury and diabetic nephropathy have been long-standing research hotspots and still hold significant values. Moreover, the use of TLR inhibitors as a therapeutic strategy for kidney diseases is increasingly emphasized.
Conclusion: Our study demonstrates a growing understanding of the crucial role of TLRs in kidney diseases over the past two decades. Future research should attach more importance to the identification of novel endogenous ligands for TLRs, which will be critical for developing TLR inhibitors as a viable therapeutic strategy.
Keywords: Toll-like receptors; bibliometric analysis; inflammation; ischemic acute kidney injury; kidney diseases.
Copyright © 2025 Liu, Luo, Wan, Li and Su.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures









Similar articles
-
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w. Online ahead of print. Updates Surg. 2025. PMID: 40580377
-
Application of non-invasive imaging in myocardial infarction: a bibliometric analysis from January 2003 to December 2022.Quant Imaging Med Surg. 2025 Jul 1;15(7):6340-6359. doi: 10.21037/qims-24-878. Epub 2025 Jun 30. Quant Imaging Med Surg. 2025. PMID: 40727351 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2023 May 15;5:CD014908. doi: 10.1002/14651858.CD014908.pub3. PMID: 36622724 Free PMC article. Updated.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous